Allogene Therapeutics
ALLO
#7184
Rank
ยฃ0.45 B
Marketcap
ยฃ1.32
Share price
0.57%
Change (1 day)
20.38%
Change (1 year)

Revenue for Allogene Therapeutics (ALLO)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of ยฃ0.01 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Allogene Therapeutics from 2018 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A-100%
2024 ยฃ0.01 M-25.55%
2023 ยฃ0.02 M-88.28%
2022 ยฃ0.2 M-99.3%
2021 ยฃ28.51 M
2020 N/A
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA